FBR Capital Starts NCI Building Systems (NCS) at Outperform
Tweet Send to a FriendGet Alerts NCS Hot Sheet
Price: $16.01 -3.15%
Rating Summary:
1 Buy, 0 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 28 | New: 13
Rating Summary:
1 Buy, 0 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 28 | New: 13
Trade NCS Now!
FBR Capital initiates coverage on NCI Building Systems (NYSE: NCS) with a Outperform. PT $17.00.
The firm is positive on the restructuring accomplished over the past several years and with demand slowly improving in certain nonresidential segments, it is well positived for revenue growth and "substantial profit margin expansion." The firm said private equity firm Clayton, Dubilier & Rice's 72.7% stake is depressing the current share price below fair value.
For an analyst ratings summary and ratings history on NCI Building Systems click here. For more ratings news on NCI Building Systems click here.
Shares of NCI Building Systems closed at $13.09 yesterday, with a 52 week range of $8.88-$13.50.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
The firm is positive on the restructuring accomplished over the past several years and with demand slowly improving in certain nonresidential segments, it is well positived for revenue growth and "substantial profit margin expansion." The firm said private equity firm Clayton, Dubilier & Rice's 72.7% stake is depressing the current share price below fair value.
For an analyst ratings summary and ratings history on NCI Building Systems click here. For more ratings news on NCI Building Systems click here.
Shares of NCI Building Systems closed at $13.09 yesterday, with a 52 week range of $8.88-$13.50.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: BTIG Starts ING U.S (VOYA) at Buy, Shares 'Significantly Undervalued'
- UPDATE: Michael Kors (KORS) Under-Appreciated; Canaccord Genuity Starts at Buy
- JMP Securities Starts Galena Biopharma (GALE) at Market Outperform
Create E-mail Alert Related Categories
New CoverageLogin with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!

